Dollar-a-dose, off-patent drug being marketed in the US for $89000 as a muscular dystrophy treatment
Deflazacort, a steroid, can be purchased online from non-US sources for $1.00, but now it’s being marketed by Illinois’s Marathon Pharmaceuticals for $89,000 as Emflaza, to treat Duchenne muscular dystrophy, which predominantly affects men in their 20s.
Marathon Pharmaceuticals to charge $89000 for muscular dystrophy drug after 70-fold increase
An old drug gets a new price to fight a rare disease: $89000 a year
Drug Company Jacks up Price of Old Drug by More Than 7000%
View original article
Powered by WPeMatico